 | • レポートコード：MRC2303H114 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、228ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査資料によると、2021年に5,269.20百万ドルであった世界の心臓弁修復＆置換デバイス市場規模は2022年に5,686.72百万ドルとなり、2027年までに年平均8.10％成長して8,408.53百万ドルまで拡大すると見込まれています。当書は、心臓弁修復＆置換デバイスの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、手術別分析（低侵襲手術、開腹手術、経カテーテル手術）、製品タイプ別分析（心臓弁修復デバイス、心臓弁置換デバイス）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、Abbott Laboratories、Affluent Medical、Aortech International Plc、Arbor Surgical Technologies, Inc.、Boston Scientific Corporation、Braile Biomedica、Colibri Heart Valve、Comed、CroíValve、CryoLife, Inc.、Edwards Lifesciences Corporationなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の心臓弁修復＆置換デバイス市場規模：手術別 - 低侵襲手術における市場規模 - 開腹手術における市場規模 - 経カテーテル手術における市場規模 ・世界の心臓弁修復＆置換デバイス市場規模：製品タイプ別 - 心臓弁修復デバイスの市場規模 - 心臓弁置換デバイスの市場規模 ・世界の心臓弁修復＆置換デバイス市場規模：地域別 - 南北アメリカの心臓弁修復＆置換デバイス市場規模 アメリカの心臓弁修復＆置換デバイス市場規模 カナダの心臓弁修復＆置換デバイス市場規模 ブラジルの心臓弁修復＆置換デバイス市場規模 ... - アジア太平洋の心臓弁修復＆置換デバイス市場規模 日本の心臓弁修復＆置換デバイス市場規模 中国の心臓弁修復＆置換デバイス市場規模 インドの心臓弁修復＆置換デバイス市場規模 韓国の心臓弁修復＆置換デバイス市場規模 台湾の心臓弁修復＆置換デバイス市場規模 ... - ヨーロッパ/中東/アフリカの心臓弁修復＆置換デバイス市場規模 イギリスの心臓弁修復＆置換デバイス市場規模 ドイツの心臓弁修復＆置換デバイス市場規模 フランスの心臓弁修復＆置換デバイス市場規模 ロシアの心臓弁修復＆置換デバイス市場規模 ... - その他地域の心臓弁修復＆置換デバイス市場規模 ・競争状況 ・企業情報 |
The Global Heart Valve Repair & Replacement Devices Market size was estimated at USD 5,269.20 million in 2021 and expected to reach USD 5,686.72 million in 2022, and is projected to grow at a CAGR 8.10% to reach USD 8,408.53 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Heart Valve Repair & Replacement Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Surgery, the market was studied across Minimally Invasive Surgeries, Open Surgeries, and Transcatheter Surgeries.
Based on Product Type, the market was studied across Heart Valve Repair Devices and Heart Valve Replacement Devices. The Heart Valve Replacement Devices is further studied across Mechanical Heart Valve, Tissue Heart Valve, and Transcatheter Heart Valve.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Heart Valve Repair & Replacement Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Heart Valve Repair & Replacement Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Heart Valve Repair & Replacement Devices Market, including Abbott Laboratories, Affluent Medical, Aortech International Plc, Arbor Surgical Technologies, Inc., Boston Scientific Corporation, Braile Biomedica, Colibri Heart Valve, Comed, CroíValve, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., Labcor, LivaNova PLC, Medtronic, Meril Life Sciences, Micro Interventional Devices, Inc., NeoChord, Neovasc, On-X Life Technologies, PulmonX, Shockwave Medical, St. Jude Medical, Symetis, Valcare Medical, Valtech, and Venus MedTech.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Heart Valve Repair & Replacement Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heart Valve Repair & Replacement Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heart Valve Repair & Replacement Devices Market?
4. What is the competitive strategic window for opportunities in the Global Heart Valve Repair & Replacement Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Heart Valve Repair & Replacement Devices Market?
6. What is the market share of the leading vendors in the Global Heart Valve Repair & Replacement Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Heart Valve Repair & Replacement Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing availability of advanced computational tools toward accurate diagnosis of valvular disease
5.1.1.2. Surge in the prevalence of cardiovascular diseases globally
5.1.1.3. Increasing geriatric population and associated cardiovascular disorders
5.1.2. Restraints
5.1.2.1. Relatively expensive device due to extensive manufacturing cost
5.1.2.2. Probability of product recalls
5.1.3. Opportunities
5.1.3.1. Technological advancements with the introduction of biodegradable devices
5.1.3.2. Rapid adoption of transcatheter heart valves globally
5.1.4. Challenges
5.1.4.1. Issues with product approval owing to complex regulatory procedures
5.2. Cumulative Impact of COVID-19
6. Heart Valve Repair & Replacement Devices Market, by Surgery
6.1. Introduction
6.2. Minimally Invasive Surgeries
6.3. Open Surgeries
6.4. Transcatheter Surgeries
7. Heart Valve Repair & Replacement Devices Market, by Product Type
7.1. Introduction
7.2. Heart Valve Repair Devices
7.3. Heart Valve Replacement Devices
7.4.1. Mechanical Heart Valve
7.4.2. Tissue Heart Valve
7.4.3. Transcatheter Heart Valve
8. Americas Heart Valve Repair & Replacement Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Heart Valve Repair & Replacement Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Heart Valve Repair & Replacement Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Affluent Medical
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Aortech International Plc
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Arbor Surgical Technologies, Inc.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Boston Scientific Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Braile Biomedica
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Colibri Heart Valve
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Comed
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. CroíValve
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. CryoLife, Inc.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Edwards Lifesciences Corporation
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. JenaValve Technology, Inc.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Labcor
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. LivaNova PLC
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Medtronic
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Meril Life Sciences
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Micro Interventional Devices, Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. NeoChord
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Neovasc
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. On-X Life Technologies
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. PulmonX
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Shockwave Medical
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. St. Jude Medical
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Symetis
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services
12.25. Valcare Medical
12.25.1. Business Overview
12.25.2. Key Executives
12.25.3. Product & Services
12.26. Valtech
12.26.1. Business Overview
12.26.2. Key Executives
12.26.3. Product & Services
12.27. Venus MedTech
12.27.1. Business Overview
12.27.2. Key Executives
12.27.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing